Denoclast 60 Mg Injection

Product Description

About Denoclast 60 mg Injection

Denoclast 60 mg Injection belongs to a group of medicines called RANK ligand inhibitors used to treat osteoporosis in postmenopausal women and men who have an increased risk of fracture. Denoclast 60 mg Injection is also used to treat bone loss due to reduced testosterone level caused by surgery,due to the treatment with medicines such as glucocorticoids and in patients with prostate cancer. Denoclast 60 mg Injection may also be used to reduce the risk of fractures in people with multiple myeloma, giant cell tumour of the bone, and to treat high calcium levels caused due to cancer.

Denoclast 60 mg Injection contains 'denosumabi, which works by blocking a receptor in the body that causes bone loss, thereby treats bone loss. Denoclast 60 mg Injection treats giant cell tumour of bone (GCTB) by blocking certain receptors in the tumour cells, thereby slowing the tumour growth. Denoclast 60 mg Injection helps treat high calcium levels by decreasing bone breakdown as a breakdown of the bones releases calcium. Denoclast 60 mg Injection makes the bones stronger and less likely to break.

Denoclast 60 mg Injection will be administered by a healthcare professional; do not self-administer. In some cases, you may experience common side-effects such as bone/joint/muscle pain, arm/leg pain, abdominal discomfort, constipation, and painful/frequent urination. You are advised to talk to your doctor if the side effects persist or worsen.

Denoclast 60 mg Injection might cause osteonecrosis of the jaw; therefore, maintain good dental hygiene and receive regular dental check-ups whilst on treatment with Denoclast 60 mg Injection. Avoid taking Denoclast 60 mg Injection if you are pregnant. Consult your doctor before taking Denoclast 60 mg Injection if you are breastfeeding. Denoclast 60 mg Injection is not recommended for children below 18 years as safety and effectiveness have not been established. Keep your doctor informed about your health condition and medicines to rule out any interactions.

How Does Denoclast 60 mg Injection Work?

Denoclast contains Denosumab, a biological agent that inhibits bone resorption by targeting specific cells involved in bone breakdown. This leads to increased bone density and reduced risk of fractures in individuals with osteoporosis or bone loss due to cancer. Its targeted action makes it highly effective in promoting bone health.


Process and Usage Instructions

Denoclast is supplied as a prefilled syringe, containing 60 mg Denosumab. The injection is given under the skin (subcutaneously) every six months, according to a doctor's instructions. It must only be administered by a qualified healthcare professional, not for self-injection. Always ensure calcium levels are normal before starting treatment.


Storage and Shelf Life Guidance

Keep Denoclast in its original packaging, stored in a refrigerator at 2C to 8C, and do not freeze. With a shelf life of 24 months from the manufacture date, proper storage maintains the stability and effectiveness of the medication.